Title of article :
Management of Baseline Measurements in Statistical Analysis of 2×2 Crossover Trials
Author/Authors :
Alavi Majd, Hamid Department of Biostatistics - Faculty of Allied Medical Sciences - Shahid Beheshti University of Medical Sciences, Tehran , Naseri, Parisa Department of Biostatistics - Faculty of Allied Medical Sciences - Shahid Beheshti University of Medical Sciences, Tehran , Momenyan, Somayeh Department of Biostatistics - Faculty of Allied Medical Sciences - Shahid Beheshti University of Medical Sciences, Tehran , Heidari, Saeideh Department of Nursing - Faculty of Nursing and Midwifery - Qom University of Medical Sciences
Abstract :
Introduction: Crossover designs have applications in a wide range of
sciences. The simplest and most common of such designs are the two-period,
two-treatment (2×2) crossover. As a consequence, each subject provides a
4×1 vector of responses for data analysis in the following chronological
order: baseline (period 1), post-baseline (period 1), baseline (period 2), and
post-baseline (period 2).
Methods: We considered three types of analytic approaches for handling the
baselines:1) analysis of variance (ANOVA) method which ignores the first or
both period baselines or use a change from baseline analysis 2) analysis of
covariance (ANCOVA) method which uses an analysis of covariance where
linear functions of one or both baselines are employed as either periodspecific
or period-invariant covariates 3) Joint modeling method that
conducts joint modeling of a linear function of the baseline and post-baseline
responses with certain mean constraints for the baseline responses. The
crossover clinical trial data was analyzed, using the proposed models.
Results: Based on the results on real data among all mentioned models, the
first model (direct comparison of post-treatment values) and the second
model (post-treatment measurement subtracts corresponding baseline) had
the lowest and the highest standard errors, respectively. With respect to
Akaike Information Criterion (AIC), the fifth model (comparison of posttreatment
values adjusted by all available baseline data) and the eighth model
(comparison of post-treatment values adjusted by difference and sum of all
available baseline data) had the lowest magnitude, and the ninth model
(modeling period baseline jointly with post-treatment values) had the highest
AIC for both variables which the values of AIC were 518.1, 520.9 and
1137.8, respectively.
Conclusion: To sum up, it is found that baseline data of crossover trial may
be used to improve the efficiency of treatment effect estimation when applied
appropriately.
Keywords :
Baseline adjustment , Covariate , Crossover trial , Carryover effect , Change scores
Journal title :
Archives of Advances in Biosciences